00157.HK
Natural Beauty Bio-Technology Limited
HKSE · Consumer Defensive · Household & Personal Products · HK
HKD 0.47
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 984.8M | 538.8M | 353.7M | 336.0M | 335.9M |
| Cost of Revenue | 512.8M | 245.5M | 151.3M | 135.7M | 170.6M |
| Gross Profit | 472.0M | 293.3M | 202.3M | 200.3M | 165.3M |
| Operating Expenses | |||||
| R&D Expense | 9.2M | 6.5M | 2.3M | 3.5M | 4.4M |
| SG&A Expense | 522.6M | 273.4M | 251.4M | 204.1M | 207.8M |
| General & Admin Expense | 113.3M | 71.8M | 80.4M | 66.0M | 68.6M |
| Selling & Marketing Expense | 287.9M | 200.3M | 171.0M | 142.2M | 139.3M |
| Other Expenses | 53.5M | (9.7M) | 48.1M | (3.5M) | (3.9M) |
| Total Operating Expenses | 585.3M | 270.2M | 299.5M | 204.1M | 208.3M |
| Cost and Expenses | 1.1B | 515.7M | 450.8M | 339.8M | 355.1M |
| Operating Income (EBIT) | (50.1M) | 23.2M | (97.2M) | (3.7M) | (19.2M) |
| Non-Operating | |||||
| Interest Income | — | 2.0M | 847.0K | 1.5M | 1.7M |
| Interest Expense | 20.0M | 10.5M | 8.0M | 8.1M | 4.3M |
| Net Interest Income | (19.7M) | (8.5M) | (7.2M) | (6.6M) | (2.7M) |
| Other Non-Op Income/Expense | (68.6M) | (11.4M) | (8.0M) | (8.1M) | (4.3M) |
| Non-Operating Income (excl Interest) | 47.6M | (4.2M) | — | — | (4.2M) |
| EBT (Pre-Tax Income) | (118.7M) | 11.8M | (105.2M) | (11.9M) | (23.5M) |
| Income Tax Expense | 1.6M | 1.2M | (1.6M) | 3.2M | 6.9M |
| Bottom Line | |||||
| Net Income | (119.7M) | 10.6M | (103.6M) | (15.1M) | (30.5M) |
| Earnings from Cont. Ops | (119.7M) | 10.6M | (103.6M) | (15.1M) | (30.5M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (119.7M) | 10.6M | (103.6M) | (15.1M) | (30.5M) |
| Per Share | |||||
| Basic EPS | (HK$0.06) | HK$0.01 | (HK$0.05) | (HK$0.01) | (HK$0.02) |
| Diluted EPS | (HK$0.06) | HK$0.01 | (HK$0.05) | (HK$0.01) | (HK$0.02) |
| Revenue Per Share | HK$0.49 | HK$0.27 | HK$0.18 | HK$0.17 | HK$0.17 |
| Shares | |||||
| Basic Shares Outstanding | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| Diluted Shares Outstanding | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| Profitability Metrics | |||||
| EBITDA | (18.1M) | 57.8M | (65.5M) | 22.9M | 15.1M |
| D&A | 79.6M | 30.4M | 31.7M | 26.6M | 34.3M |
| EBIT | (97.7M) | 27.4M | (97.2M) | (3.7M) | (19.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026